Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
Amoury M, Bauerschlag D, Zeppernick F, von Felbert V, Berges N, Di Fiore S, Mintert I, Bleilevens A, Maass N, Bräutigam K, Meinhold-Heerlein I, Stickeler E, Barth S, Fischer R, Hussain AF.
Amoury M, et al. Among authors: fischer r.
Oncotarget. 2016 Aug 23;7(34):54925-54936. doi: 10.18632/oncotarget.10705.
Oncotarget. 2016.
PMID: 27448975
Free PMC article.